> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# West Pharmaceutical Stock Surges 7%, Adding $1.9 Billion, As Company Lifts 2026 Outlook
- URL: https://www.bullished.co/west-pharmaceutical-stock-surges-7-adding-1-9-billion-as-company-lifts-2026-outlook-f0c470fb/
- Published: 2026-10-29T15:48:20.000Z
- Updated: 2026-10-29T15:48:20.000Z
- Description: The injectable-drug packaging supplier raised its 2026 sales and earnings targets, but guided fourth-quarter growth well below the third quarter.
- Author: Matteo Parrino
- Tags: Markets, WST, Industry: Healthcare

[West Pharmaceutical](https://www.bullished.co/tag/wst/), which makes containment and delivery systems for injectable drugs, saw its shares climb 6.66% to $430.54 in Thursday trading, as of 11:47 a.m. ET, a new 52-week high that added about $1.9 billion in market value. The move followed a third-quarter report that [raised the company's 2026 forecast](https://www.sec.gov/Archives/edgar/data/0000105770/000010577026000118/wst-20261029.htm?ref=bullished.co) for sales and adjusted earnings.

## A raised outlook on wider margins

Third-quarter revenue was [$874.5 million](https://seekingalpha.com/news/4659985-west-pharmaceutical-beats-top-line-and-bottom-line-estimates-raises-fy26-outlook?ref=bullished.co), up 8.7% from a year earlier, with adjusted earnings of $2.66 a share, the company reported. Investors responded to stronger margins on premium vial stoppers.

West now expects 2026 revenue of [$3.41 billion to $3.42 billion](https://www.benzinga.com/news/26/10/62694662/west-pharmaceutical-servs-q3-2026-earnings-call-transcript?ref=bullished.co) and adjusted earnings of $9.38 to $9.48 per share. It also said it bought back $231 million of its stock in the quarter.

The shares were on pace for a fourth straight daily gain and their biggest one-day rise since April 23\. West's market value stood at $30.3 billion Thursday.

## A beat with a cooling fourth quarter

Management said on the [earnings call](https://www.benzinga.com/news/26/10/62694662/west-pharmaceutical-servs-q3-2026-earnings-call-transcript?ref=bullished.co) that the margin gains are not "the New Floor," and guided fourth-quarter growth well below the third quarter's pace.

High-value components, led by GLP-1-related products, made up 53% of revenue, the company said.

## Up 47% this year

West sells stoppers, seals, syringe and cartridge components, vials and self-injection devices to biologic, generic, pharmaceutical, diagnostic and medical device companies. Its revenue comes from two segments: Proprietary Products, sold mainly to drug companies, and Contract-Manufactured Products, which designs and assembles complex devices.

The stock was up about 47% year to date as of Wednesday's close, well ahead of the S&P 500's roughly 13% gain.

Thursday's rally leaves the stock at a 52-week high, set against management's own warning that fourth-quarter growth will be well below the third quarter's.

### Sources

- [West Pharmaceutical Services (WST) Q3 Earnings and Revenues Top Estimates](https://finance.yahoo.com/markets/stocks/articles/west-pharmaceutical-services-wst-q3-101003271.html?.tsrc=rss&ref=bullished.co) — Yahoo Finance
- [West Pharmaceutical beats top-line and bottom-line estimates; raises FY26 outlook | Seeking Alpha](https://seekingalpha.com/news/4659985-west-pharmaceutical-beats-top-line-and-bottom-line-estimates-raises-fy26-outlook?ref=bullished.co) — seekingalpha.com
- [Compared to Estimates, West Pharmaceutical (WST) Q3 Earnings: A Look at Key Metrics](https://finance.yahoo.com/markets/stocks/articles/compared-estimates-west-pharmaceutical-wst-123006251.html?.tsrc=rss&ref=bullished.co) — Yahoo Finance
- [West Pharmaceutical Servs Q3 2026 Earnings Call Transcript](https://www.benzinga.com/news/26/10/62694662/west-pharmaceutical-servs-q3-2026-earnings-call-transcript?ref=bullished.co) — benzinga.com
- [West (WST) Stock Could Be 28% Overvalued As Cash Flow Falls Short](https://sg.finance.yahoo.com/news/west-wst-stock-could-28-011133863.html?ref=bullished.co) — Yahoo Finance
- [The company's filing (West Pharmaceutical)](https://www.sec.gov/Archives/edgar/data/0000105770/000010577026000118/wst-20261029.htm?ref=bullished.co) — SEC filing
- [West Pharmaceutical — Form 10-Q for the quarter ended 2026-06-30 (quarterly results)](https://www.sec.gov/Archives/edgar/data/105770/000010577026000099/wst-20260630.htm?ref=bullished.co) — SEC EDGAR

### More on West Pharmaceutical

- [West Pharmaceutical Says GLP-1 Surge Had 'Nothing One-Offish' — But Margins Are Not 'The New Floor'](https://www.bullished.co/west-pharmaceutical-says-glp-1-surge-had-nothing-one-offish-but-margins-are-not-the-new-6401a116/)
- [West Pharmaceutical's New CEO Says The Bar For Acquisitions Is 'Incredibly High' As Customers Cut Supplier Lists](https://www.bullished.co/west-pharmaceuticals-new-ceo-says-the-bar-for-acquisitions-is-incredibly-high-as-customers-6faf3bb0/)
- [West Pharmaceutical Raises 2026 Profit Outlook To $9.38-$9.48 A Share As High-Value Components Jump 19.7%](https://www.bullished.co/west-pharmaceutical-raises-2026-profit-outlook-to-9-38-9-48-a-share-as-high-value-af17e470/)

[All West Pharmaceutical (WST) coverage →](https://www.bullished.co/tag/wst/)